PAK2 is an effector of TSC1/2 signaling independent of mTOR and a potential therapeutic target for Tuberous Sclerosis Complex
Maria M. Alves(Erasmus MC), Maikel P. Peppelenbosch(Erasmus MC)
Cited by 47
Related Papers
Cytotoxicity of apigenin on leukemia cell lines: implications for prevention and therapy
|Cell Death and Disease|2010|190
Cyclooxygenase-2 Inhibition Inhibits c-Met Kinase Activity and Wnt Activity in Colon Cancer
|Cancer Research|2008|129